Core Insights - RxSight, Inc. will report its financial results for Q2 2025 on August 7, 2025, after market close [1] - A conference call to discuss the results will take place at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time [1] Company Overview - RxSight, Inc. specializes in ophthalmic medical devices, focusing on customized vision solutions for patients post-cataract surgery [3] - The company offers the RxSight® Light Adjustable Lens system, which is the first and only intraocular lens technology that can be adjusted after surgery [3] - This technology allows doctors to provide tailored high-quality vision to patients following cataract procedures [3] Contact Information - Chief Financial Officer: Shelley B. Thunen, Email: sthunen@rxsight.com [4] - VP, Investor Relations: Oliver Moravcevic, Email: omoravcevic@rxsight.com [4]
RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025